Cargando…
DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma
BACKGROUND: Skin cutaneous melanoma (SKCM) is a highly malignant skin tumor. DIRAS2 is considered to be a tumor suppressor gene; however, its function in SKCM has not been explored. METHODS: The Gene Expression Profiling Interactive Analysis (GEPIA) was implemented to investigate the expression of D...
Autores principales: | Xue, Wenli, Zhu, Hongbo, Liu, Hongye, He, Hongxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149220/ https://www.ncbi.nlm.nih.gov/pubmed/35651810 http://dx.doi.org/10.3389/fonc.2022.799185 |
Ejemplares similares
-
ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma
por: Deng, TengFei, et al.
Publicado: (2023) -
CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023) -
Prognostic biomarker CCR6 and its correlation with immune infiltration in cutaneous melanoma
por: Nurzat, Yeltai, et al.
Publicado: (2023) -
Tú dirás!
por: Gutiérrez, Jhon R.
Publicado: (1999) -
Frequent Epigenetic Inactivation of DIRAS-1 and DIRAS-2 Contributes to Chemo-Resistance in Gliomas
por: Rothhammer-Hampl, Tanja, et al.
Publicado: (2021)